FDA Warns Cosmetics Firm on Unapproved, Misbranded Drugs
The Food and Drug Administration has issued a warning letter to Lifetech Resources LLC regarding its manufacturing, distribution, and promotion of RapidLash Eyelash Renewal Serum, NeuLash Active Eyelash Technology, and NeuveauBrow Active Eyebrow Technology, which FDA states are unapproved and…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
misbranded drugs and violate provisions of the Federal Food, Drug, and Cosmetic Act. FDA urges LifeTech to take prompt action to correct the violations, and states that failure to promptly correct the violations may result in legal action, including seizure and injunction.